Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MPX
2101
DELISTED
Marine Products Corp
MPX
| $2.53M | ﹤0.01% |
182,218
+51,118
| +39% | +$553K |
|
|
CNBKA
2102
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $2.53M | ﹤0.01% |
42,100
+14,800
| +54% | +$769K |
|
2103
MSCI
MSCI
$41.4B
| $2.51M | ﹤0.01% |
31,821
-54,000
| -63% | -$4.35M |
|
|
P
2104
Everpure Inc
P
$39.3B
| $2.5M | ﹤0.01% |
+221,300
| New | +$2.87M |
|
2105
Greif Class B
GEF.B
$4.2B
| $2.5M | ﹤0.01% |
37,000
+3,422
| +10% | +$221K |
|
2106
inTEST
INTT
$179M
| $2.5M | ﹤0.01% |
543,000
+6,000
| +1% | +$25.1K |
|
2107
Sportsman's Warehouse
SPWH
$46.4M
| $2.49M | ﹤0.01% |
+265,574
| New | +$2.52M |
|
2108
Lifetime Brands
LCUT
$226M
| $2.48M | ﹤0.01% |
140,000
-5,000
| -3% | -$79K |
|
2109
John B. Sanfilippo & Son
JBSS
$1.01B
| $2.48M | ﹤0.01% |
35,271
-119,229
| -77% | -$7.33M |
|
|
DX
2110
Dynex Capital
DX
$3.24B
| $2.48M | ﹤0.01% |
121,007
+51,074
| +73% | +$1.05M |
|
|
BCRH
2111
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $2.48M | ﹤0.01% |
134,200
+39,001
| +41% | +$705K |
|
|
CCRN
2112
DELISTED
Cross Country Healthcare
CCRN
| $2.47M | ﹤0.01% |
158,018
+112,101
| +244% | +$1.54M |
|
|
NM
2113
DELISTED
Navios Maritime Holdings Inc.
NM
| $2.47M | ﹤0.01% |
174,880
+47,520
| +37% | +$633K |
|
2114
AMES National
ATLO
$280M
| $2.46M | ﹤0.01% |
74,556
+12,156
| +19% | +$363K |
|
2115
NGL Energy Partners
NGL
$2.24B
| $2.46M | ﹤0.01% |
117,100
-54,000
| -32% | -$1.02M |
|
2116
AMERISAFE
AMSF
$513M
| $2.46M | ﹤0.01% |
39,400
-1,200
| -3% | -$72.8K |
|
2117
Beazer Homes USA
BZH
$872M
| $2.45M | ﹤0.01% |
+184,160
| New | +$2.28M |
|
|
CXDC
2118
DELISTED
China XD Plastics Company Limited
CXDC
| $2.44M | ﹤0.01% |
610,900
+6,500
| +1% | +$28.7K |
|
2119
Independence Realty Trust
IRT
$4.01B
| $2.44M | ﹤0.01% |
273,900
-378,195
| -58% | -$3.27M |
|
2120
Nomad Foods
NOMD
$1.64B
| $2.44M | ﹤0.01% |
255,200
-394,100
| -61% | -$4.3M |
|
|
CVRR
2121
DELISTED
CVR Refining, LP
CVRR
| $2.44M | ﹤0.01% |
+234,600
| New | +$2.05M |
|
|
GIG
2122
DELISTED
GigPeak, Inc.
GIG
| $2.44M | ﹤0.01% |
966,800
-410,000
| -30% | -$1.06M |
|
|
WFBI
2123
DELISTED
WashingtonFirst Bankshares Inc
WFBI
| $2.43M | ﹤0.01% |
+83,735
| New | +$2.11M |
|
2124
Banner Corp
BANR
$2.52B
| $2.42M | ﹤0.01% |
43,391
-205,808
| -83% | -$10.1M |
|
|
TUP
2125
DELISTED
Tupperware Brands Corporation
TUP
| $2.42M | ﹤0.01% |
46,000
-8,900
| -16% | -$522K |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.